NGS-based RNA-seq market is estimated to reach US$ 7,984.90 Mn with a CAGR of 19.3% Till 2027 with Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., Qaigen and others
NGS-based RNA-seq market is estimated to reach US$ 7,984.90 Mn with a CAGR of 19.3% Till 2027 with Illumina, Inc., Thermo Fisher Scientific Inc., Pacific B
Source: sandiegosun.com